Laboratory or Test Result – Talk Bio

Actionable Insights Powered by AI

United Therapeutics’ Tyvaso Succeeds in Phase 3 IPF Trial, Marking Major Advance in Lung Disease Treatment

1 week ago talkbio0Tagged Clinical Trials, Forced Vital Capacity, Idiopathic Pulmonary Fibrosis, IPF, Lung diseases, nebulized body site, Pulmonary Fibrosis, TETON-2, Tyvaso, United States Food and Drug Administration, United Therapeutics, Vital capacity test

Tyvaso; United Therapeutics; idiopathic pulmonary fibrosis; IPF; Phase 3 trial; TETON-2; lung disease; forced vital capacity; FVC; clinical trial; FDA; nebulized treprostinil

Argenx’s Vyvgart Shows Positive Phase 3 Results in Seronegative Myasthenia Gravis

2 weeks ago talkbio0Tagged AChR-Ab, Adaptation, Argenx, expansion, Labels (device), LRP4 gene, Musk, Myasthenia Gravis, Phase 3, SERON, Seronegative, triple seronegative, United States Food and Drug Administration, Vyvgart

Vyvgart; Argenx; Phase 3; myasthenia gravis; seronegative; ADAPT SERON; AChR-Ab; MuSK+; LRP4+; triple seronegative; FDA label expansion

Illumina and Tempus look beyond cancer in new AI-driven genomics deal

5 months ago talkbio0Tagged Artificial Intelligence, Cardiology discipline, Genetic Profile, Genomics, High-Throughput Nucleotide Sequencing, Illumina, Immunology, Malignant Neoplasms, Market, Neurology speciality, Partnership

Illumina, Genomics, Partnership, High-Throughput Nucleotide Sequencing, Malignant Neoplasms, Artificial Intelligence, Cardiology discipline, Neurology speciality, Immunology, Genetic Profile, Artificial Intelligence, Market

Isomorphic Labs Secures $600M to Accelerate AI-Powered Drug Discovery

5 months ago talkbio0Tagged Antibodies, Aortic Valve Insufficiency, Demis, expansion, Hassabis, Isomorphous, Laboratory test finding, U.S.

AI drug discovery, Isomorphic Labs, Demis Hassabis, funding round, antibodies, US expansion

Isomorphic Labs raises $600M to push AI-designed drugs into clinic

5 months ago talkbio0Tagged AI-designed, development aspects, Isomorphous, Laboratory test finding

Isomorphous, Laboratory test finding, development aspects, AI-designed

Lila Sciences Emerges with $200M to Build AI-Powered Scientific Superintelligence Platform

6 months ago talkbio0Tagged Aortic Valve Insufficiency, autonomous, Flagship, Laboratory test finding, Pioneering, Plant seeds, scientific discovery

AI, scientific discovery, autonomous labs, Flagship Pioneering, seed funding

Leyden Labs Secures $70 Million Funding to Develop Broad Protection Against Respiratory Viruses

8 months ago talkbio0Tagged biotech, Laboratory test finding, Leyden, Mucosal Protection Platform, Nasal, Nasal defenses, PanFlu, Protection, Respiratory viruses

Leyden Labs, Respiratory viruses, Influenza, Nasal defenses, Broad protection, PanFlu, Mucosal Protection Platform, Biotech funding

Lilly’s Oral SERD Imlunestrant Shows Significant Progression-Free Survival Benefits in ER+, HER2- Advanced Breast Cancer

9 months ago talkbio0Tagged CDK4/6 inhibitor, ESR1 gene, Estrogen receptor positive, HER2-, Imlunestrant, Malignant neoplasm of breast, Mutation, Oral SERD, Progression-Free Survival, Verzenio

Imlunestrant, Verzenio, oral SERD, ER+, HER2-, advanced breast cancer, progression-free survival, ESR1 mutation, CDK4/6 inhibitor

Negev Labs Unveils Next-Gen Psychedelic Therapies with Non-Hallucinogenic Neuroplastogens

9 months ago talkbio0Tagged Biotechnology, Builder, Hallucinogens, Laboratory test finding, mental health, Negev, neuroplastogens, non-hallucinogenic, psychedelic therapies

Negev Labs, neuroplastogens, psychedelic therapies, non-hallucinogenic psychedelics, mental health treatments, biotechnology company builder

Shattuck Labs Shifts Focus to IBD Drug, Discontinues CD47 Program and Reduces Workforce by 40%

11 months ago talkbio0Tagged Antibodies, CD47 Antigen, Inflammatory Bowel Diseases, Laboratory test finding, Programs - Publication Format, Shattuck, SL 325, TNFRSF25 gene

Shattuck Labs, CD47 program, workforce reduction, IBD drug, SL-325, DR3 antagonist antibody